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Abstract
Background—Compared with other racial groups, African Americans have the highest
colorectal cancer (CRC) incidence and mortality rates coupled with lower screening rates.
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Objective—Our study examined the predictors of stage of adoption for fecal occult blood testing
(FOBT) and colonoscopy among African American primary care patients who were non-adherent
to published screening guidelines.
Methods—Baseline data (N = 815) in a randomized clinical trial were analyzed. Participants
were categorized into precontemplation, contemplation, and preparation stages for FOBT and
colonoscopy. Predictor variables were demographics, clinical variables, CRC health beliefs and
knowledge, and social support. Hierarchical modeling was to identify significant predictors of
stage of adoption.
Results—Older, male, Veterans Affairs participants and those with higher perceived self-
efficacy, family/friend encouragement, and a provider recommendation had higher odds of being
at a more advanced stage of adoption for FOBT. Patients with a history of cancer and higher
perceived barriers had higher odds of being at an earlier stage of adoption for FOBT. Predictors of
more advanced stage of adoption for colonoscopy included higher perceived benefits, higher
perceived self-efficacy, family/friend encouragement, and a provider recommendation for
colonoscopy. Higher income (> 30K vs. < 15K) was predictive of earlier stage of adoption for
colonoscopy.
Conclusions—Enhancing self-efficacy, encouragement from family and friends, and provider
recommendations are important components of interventions to promote CRC screening.
Implications for Practice—Nurses can utilize knowledge of the characteristics associated with
stage of adoption to educate and motivate their African American primary care patients to
complete CRC screening tests.
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Colorectal cancer (CRC) remained the third most commonly diagnosed cancer and the third
leading cause of cancer deaths in the United States in 2012.1 African Americans have the
highest CRC incidence and mortality rates of all racial groups.2 This racial disparity has
been attributed to limited access to quality care, failure of providers to recommend
screening, and low rates of participation when screening is offered.3 Differences in genetics
and in tumor characteristics among African Americans may also contribute to poor CRC
outcomes.3, 4
Studies have demonstrated the effectiveness of screening in reducing CRC incidence and
mortality.5, 6 Individuals are at average risk for developing CRC if they have no known risk
factors other than age, and screening guidelines recommend screening begin at age 50.7
There are multiple CRC screening test options, but fecal occult blood test (FOBT) and
colonoscopy are the most commonly used CRC screening tests.8
Although CRC screening rates have improved over the last two decades, they remain
suboptimal for all Americans and are lowest among racial and ethnic minorities. The most
recent data show that rates of CRC screening with FOBT or endoscopy (sigmoidoscopy or
colonoscopy) among Non-Hispanic Caucasians 50 years of age and older was 61.5%, but
only 55.5% among Non-Hispanic African Americans.7 Given their higher CRC incidence
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and mortality rates, there is an urgent need to increase screening participation among
African Americans.
Primary care practice is often the first place for delivery of CRC screening services
including education, recommendations, and prescriptions for screening tests.9 Standard
educational materials to promote CRC screening have been disappointingly unsuccessful.10
Multiple studies suggest that theory-based tailored messages to increase screening are more
likely to be successful, especially those tailored to stage of adoption.11-13 In order to
understand how to promote CRC screening behavior among primary care African American
patients, we analyzed baseline data from a large randomized controlled trial (RCT) that
tested a computer-delivered tailored intervention to promote CRC screening among African
American primary care patients who were non-adherent to current screening guidelines.14
Conceptual Framework
Our conceptual framework includes stage of adoption as the outcome variable and four
domains of predictor variables (See Figure). The Transtheoretical Model (TTM) describes
behavior change as a dynamic process through which individuals move in a series of
discrete phases, or stages, of adoption - from precontemplation to action to maintenance.15
In our study, we enrolled only African American primary care patients who were not in the
action or maintenance stages for CRC screening. Therefore, at baseline, participants were
categorized into one of three stages of adoption for each CRC screening test separately:
precontemplation, contemplation, and preparation. The criteria for defining stages of
adoption for FOBT and colonoscopy are shown in Table 1.
The predictor variables were selected from the empirical evidence. Relationships between
these variables and CRC screening behaviors (action stage) have been found in previous
studies.8, 12, 16-18 We grouped the predictor variables based on their conceptual similarity.
The four domains of predictor variables include demographic, clinical, CRC health beliefs
and knowledge, and social support variables. They are arranged from non-modifiable,
individual factors (i.e., demographics, clinical variables) to modifiable, interpersonal factors
(i.e., CRC health beliefs and knowledge, social support). Our study examined predictors of
stage of adoption for CRC screening among African American primary care patients. We
conducted these analyses to answer the following research questions. Among African
American primary care patients who were non-adherent to CRC screening guidelines:
1. Which demographic, clinical, CRC health beliefs and knowledge, and social
support variables predict stage of adoption for FOBT, and what are the relative
contributions of each domain to the total variance explained?
2. Which demographic, clinical, CRC health beliefs and knowledge, and social
support variables predict stage of adoption for colonoscopy, and what are the
relative contributions of each domain to the total variance explained?
Methods
Our descriptive analysis used baseline data from 817 primary care patients enrolled in the
RCT to test a computer-delivered tailored intervention to promote CRC screening.14 A total
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of 817 subjects were enrolled in the RCT; however, the baseline stage of adoption was
unavailable for two different participants for each test (FOBT: n=815; colonoscopy: n=815).
Participants were recruited from 11 Midwestern urban primary care clinics: 5 community-
based clinics affiliated with a safety-net hospital, 1 university-affiliated family medicine
clinic, 1 clinic affiliated with a large, multi-hospital health care system, and 4 Veterans
Affairs (VA) clinics. Recruiters identified potentially eligible participants from clinic
databases and obtained health care provider approval prior to contact. Patients with
upcoming primary care visits were mailed an introductory letter (signed by their provider), a
recruitment brochure explaining the study, and an informed consent document. Within one
week of this mailing, patients who had not called the research office to decline participation
were contacted by a recruiter, who assessed eligibility, explained the study, answered
questions, and obtained verbal consent. Patients were eligible if they were 51 to 80 years of
age, English-speaking, self-identified as Black or African American, and were currently
non-adherent to CRC screening guidelines (no FOBT in the past 12 months, no colonoscopy
in the past 10 years, and no sigmoidoscopy in the past 5 years). Exclusion criteria included
having a personal history of CRC or adenomatous polyps requiring surveillance
colonoscopy; any medical condition that prohibited CRC screening; or a cognitive, speech,
or hearing impairment.
Eligible patients who consented to participate were scheduled for a 30 minute baseline
interview. Data were collected by trained interviewers using a computer-assisted telephone
interview system. All study procedures were HIPAA Privacy and Security Rules compliant
and were approved by the Indiana University Institutional Review Board (IRB) prior to
implementation.
Measures
Outcome Variable—The outcome variable -- stage of adoption for CRC screening-- was
assessed separately for FOBT and colonoscopy via an adapted version of Prochaska and
DiClemente's Transtheoretical Model.19 For each test, three items assessed whether
participants: 1) had the test within the recommended time frame; 2) were planning to
complete the test in the next 6 months; and 3) had an FOBT kit at home or a colonoscopy
appointment scheduled. If a participant responded “No” to all three items, s/he was
categorized into the precontemplation stage for that test. If the answer to the first item was
“No,” the second item was “Yes” and the third item was “No,” s/he was categorized into the
contemplation stage for that test. If the answer to the first item was “No,” the second item
was “Yes” and the third item was “Yes,“ s/he was categorized into the preparation stage for
that test (Table 1).
Predictor Variables—The four domains of predictor variables were assessed as follows.
Demographics including age, gender, education, employment, income, and health insurance
were obtained via self-report. Recruitment sites were dichotomized into VA clinics or non-
VA sites. The VA Healthcare System launched quality improvement initiatives to increase
CRC screening after our RCT was initiated,20 so we accounted for this difference in our
analysis plan. The non-VA clinics were all part of an urban safety net hospital system that
provided primary care for low income, predominantly minority populations.
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Clinical variables included body mass index (BMI), family history of CRC, personal history
of cancer (other than CRC), and objective risk for CRC. BMI was calculated from self-
reported body weight and height. Family history of CRC and personal history of cancer were
assessed using two single items. Objective risk for CRC was coded as “average risk” for
those who had no CRC risk factors other than age and as “increased risk” for participants
who had: 1) more than one first degree blood relative with CRC; or 2) one first degree blood
relative who was diagnosed with CRC before the age of 60.21
Health beliefs and knowledge included CRC perceived risk, perceived benefits, perceived
barriers, self-efficacy, cancer fatalism, and knowledge. Perceived risk (susceptibility) was
assessed using two measures: a 5 item Likert-type scale to measure perceived risk22 and a
single item measure of perceived (age-adjusted) comparative risk.23 The perceived risk scale
used these response options: 1 = “very likely” to 4 =“very unlikely” to assess participants'
beliefs about how likely they were to get CRC in the next 5 years, 10 years, or sometime
during their lifetime. The Cronbach's alpha for this 5 item scale was 0.79 in our study.
Perceived comparative risk was assessed by “Compared to other (men/women) your age,
would you say your chance of getting colon cancer in the next ten years is…?”.23 Response
options were “lower,” “about the same,” or “higher than others my age.”
Perceived benefits, barriers, and self-efficacy were measured for FOBT and colonoscopy
separately using valid and reliable Likert scales with four response options.24 For perceived
benefits and barriers, the response options ranged from 1=“strongly disagree” to 4=“strongly
agree.”24 The FOBT benefits scale contained 3 items (alpha = 0.72), while the colonoscopy
benefits scale had 4 items (alpha = 0.69). The FOBT barriers scale contained 9 items (alpha
= 0.81); the colonoscopy barriers scale had 15 items (alpha = 0.89). Self-efficacy for CRC
screening was measured for FOBT (8 items) and colonoscopy (11 items) by asking
participants to indicate how sure they were that they could take the steps necessary to
complete the test (alpha = 0.88 for both tests). Four response options were provided ranging
from 1= “not at all sure” to 4= “very sure.”
Cancer fatalism was measured using Mayo's modification of the Powe Fatalism Inventory,
which assesses the degree to which a person equates cancer with death.25 Eleven items were
used to assess fear, pessimism, predetermination, and the inevitability of death. Participants
selected from four response options ranging from 1=“strongly disagree” to 4=“strongly
agree.” Support for validity and reliability has been reported.26 The Cronbach's alpha for
this scale was 0.86 in our study.
CRC knowledge was measured using 11 questions. Several aspects of knowledge about
CRC were assessed, including risk factors, screening test options, and test frequency.
Knowledge scores were computed by summing the number of correct responses (possible
range: 0-11). This multidimensional instrument had an alpha coefficient of 0.64 and its
validity has been previously reported.24
Social support included marital status, family/friend encouragement of CRC screening, and
provider recommendation for each CRC screening test; all were assessed using single items.
Marital status was obtained via self-report. Participants were asked whether family or
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friends had ever encouraged them to have a colon test and whether their provider had ever
recommended they have an FOBT and a colonoscopy.
Statistical Analyses
Descriptive statistics were used to analyze participants' characteristics and the distribution of
stage of adoption. For each stage, means and standard deviations were calculated for
continuous variables, and frequencies with percentages were calculated for the categorical
variables.
Hierarchical modeling was performed based on our proposed conceptual framework to
identify predictors of stage of adoption for CRC screening, in which non-modifiable,
individual-level variables were entered first (i.e., demographics) followed by clinical
variables, and the more modifiable/interpersonal variables were entered later in the
following order: CRC health beliefs and knowledge variables, then social support variables.
Stage of adoption for FOBT and colonoscopy were modeled separately using ordinal logistic
regression to address the research questions. The models assumed that the odds for
comparing precontemplation to contemplation and preparation were the same as the odds for
comparing precontemplation and contemplation to preparation (the proportional odds
assumption). In other words, for each model fit, one set of parameter estimates can be used
to describe both comparisons. This is advantageous with regard to interpretation over having
two separate sets of estimates. The proportional odds assumption was checked for the
models, and it was not found to be violated, which indicated that the ordinal logistic
regression model was an appropriate method for this analysis. We modeled the log-odds of
being at a more advanced stage of adoption. Thus, when a predictor had an odds ratio
greater than 1, this meant that participants with this predictor had higher odds of being at a
more advanced stage of adoption or closer to action. On the other hand, when a predictor
had an odds ratio of less than 1, this meant that participants with this predictor had higher
odds of being at an earlier stage of adoption, thus further away from action.
Post hoc power calculations conducted using the popower and bpower functions of the
statistical package R27 show that, given our sample sizes per response (Table 2), we had
82% and 86% power, respectively, for FOBT and colonoscopy to detect an odds ratio of 1.5
for a dichotomous predictor that divides the total sample into two equal groups or a
continuous predictor split at the median. In comparison, if we had had equal numbers of
participants at each stage, our power would have been 88% and if we had combined
preparation with contemplation, our power would have been 82% in both cases. Thus, there
was some loss of power due to the imbalance in percentages of participants at each stage;
however, the power was still adequate for our objectives and comparable to (for FOBT) or
better than (for colonoscopy) binary logistic regression.
First, bivariate ordinal logistic regression models were used to examine the association of
each FOBT stage or colonoscopy stage with each predictor variable in the conceptual
framework. Predictor variables with a p value of 0.20 or below from bivariate analyses were
selected for the multivariable analysis. Next, multivariable ordinal logistic regression
models were used to explore the effects of various predictors on FOBT and colonoscopy
stages. Demographic variables were included in the model as predictor variables in the first
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step, then a series of clinical variables, CRC health beliefs and knowledge variables, and
social support variables were added to the model in each of the subsequent steps. The final
model (Step 4) included all predictor variables. The models were compared sequentially,
i.e., Step 2 vs. Step 1, Step 3 vs. Step 2, and Step 4 vs. Step 3 to assess the additive
contribution of each block of predictor variables (i.e., demographics, clinical variables, CRC
health beliefs and knowledge, and social support) in explaining the variance associated with
stage of adoption for FOBT and colonoscopy, respectively. Generalized R2 was reported for
each step of the modeling process. All analyses were performed using SAS (Version 9.3,
Copyright © 2008 SAS Institute Inc., Cary, NC).
After our RCT was launched, the VA Healthcare System implemented quality improvement
initiatives to increase CRC screening.20 Whether or not these initiatives could have
threatened the validity of our results was uncertain. Therefore, we conducted a post-hoc
sensitivity analyses to determine if a VA site was a significant predictor of stage of adoption
for either FOBT or colonoscopy. In these analyses, we could examine whether the results
from the hierarchical models were substantially changed by excluding the data from the VA
participants.
Results
Sample Description
Among the total sample (Table 2), the mean age was 57.4 years (range: 51-80), the average
education was 12.2 years (range: 3-18), and half of the participants were female (53%). The
majority of participants were not married or partnered (69%), not currently employed (79%),
not VA patients (80%), and had no personal history of cancer (92%) or family history of
CRC (74%). The majority had insurance (89%) and reported annual incomes of less than
$15,000 (59%). The mean BMI of this group was above 30, indicating that most participants
were obese.28 For FOBT, 59% (n = 484) were in precontemplation, 34% (n = 277) in
contemplation, and 7% (n = 54) in preparation. For colonoscopy, 43% (n = 353) were in
precontemplation, 46% (n = 378) in contemplation, and 11% (n = 84) in preparation. The
characteristics of participants at each stage, with bivariate analysis results, are shown in
Table 2.
Research Question 1: Which demographic, clinical, CRC health beliefs and knowledge,
and social support variables predict stage of adoption for FOBT, and what are the relative
contributions of each domain to the total variance explained?
The hierarchical models predicting the FOBT stage are summarized in Table 3. Based on the
conceptual model and the results from the bivariate analysis, the demographic variables of
age, male gender, income, insurance, and VA site were entered in Step 1. The clinical
variables of BMI and personal history of cancer were entered in Step 2; the CRC health
beliefs and knowledge variables of CRC perceived risk, perceived FOBT benefits, perceived
FOBT barriers, and perceived FOBT self-efficacy were entered in Step 3; and the social
support variables of marital status, family or friend encouragement of CRC tests, and
provider recommendation of FOBT were entered in Step 4. The final model (Step 4) showed
that participants who were older (OR = 1.04, p = .003); male (OR = 1.70, p = .007); seen at a
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VA site (OR = 2.80, p < .001); had greater perceived FOBT self-efficacy (OR = 1.59, p = .
007); had family or friend encouragement of CRC testing (OR = 1.64, p = .004); and had a
provider recommendation for FOBT (OR = 2.05, p < .001) had higher odds of being at a
more advanced stage for FOBT (closer to action). Participants with a personal history of
cancer (OR = 0.37, p = .002) and with greater perceived FOBT barriers (OR = 0.79, p = .
042) had higher odds of being at an earlier stage of adoption for FOBT. The four blocks of
variables combined explained 20.2% of the variance in FOBT stage. In addition, statistically
significant improvements in the amount of variance explained (generalized R2) were
observed at each step, with greater increases at Step 3 and Step 4 compared to Step 2.
Research Question 2: Which demographic, clinical, CRC health beliefs and knowledge,
and social support variables predict stage of adoption for colonoscopy, and what are the
relative contributions of each domain to the total variance explained?
The hierarchical models predicting colonoscopy stage are summarized in Table 4. The
demographic variables of age, education, male gender, income, and insurance were entered
in Step 1; the clinical variable BMI was entered in Step 2; the CRC health beliefs and
knowledge variables of CRC perceived risk, perceived comparable risk, perceived
colonoscopy benefits, perceived colonoscopy barriers, and perceived colonoscopy self-
efficacy were entered in Step 3; and the social support variables of family or friend
encouragement of CRC tests, and provider recommendation of colonoscopy were entered in
Step 4. The final model (Step 4) showed that participants who had: higher perceived
colonoscopy benefits (OR = 1.56, p < .001); higher perceived colonoscopy self-efficacy (OR
= 1.66, p < .001); family or friend encouragement of CRC tests (OR = 1.71, p = .001); and a
provider recommendation for colonoscopy (OR = 2.47, p < .001) had higher odds of being at
a more advanced stage for colonoscopy. Compared to participants with incomes of less than
$15,000, those with incomes greater than $30,000 (OR = 0.46, p = .005) had higher odds of
being at an earlier stage of adoption for colonoscopy. The four blocks of variables combined
explained 16.2% of the variance of colonoscopy stage. In addition, statistically significant
improvements in the amount of variance explained (generalized R2) were observed at each
step. Again, improvements tended to be higher at Step 3 and Step 4 than at Step 2.
Post Hoc Sensitivity Analyses
The VA site was a significant predictor of a more advanced stage for FOBT screening.
Therefore, post hoc sensitivity analyses were conducted to assess whether the results
changed substantively by excluding data from participants seen at the VA site. When data
from VA participants were excluded, there were no substantive differences in which
variables were significant compared to the primary analyses for FOBT stage. However, the
generalized R square was considerably lower at the final step (0.202 for the full sample [n
=815] vs. 0.115 for the non-VA sample [n = 653]). We also investigated whether the
potential correlation of outcomes within the clinics could be impacting the model results by
fitting additional ordinal logistic regression models that adjusted for this correlation using
generalized estimating equations. We again found no substantive changes in terms of which
predictor variables were significantly related to the outcomes.
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Discussion
Distribution of Stage of Adoption
The distribution across stages of adoption in our sample of African American primary care
patients was similar to that found in previous studies. For FOBT, the majority of participants
were not thinking about this test (i.e., in precontemplation). Similar results were found in
studies among lower income community members,29 first-degree relatives of people with
colorectal cancer,30 and insured participants.12 For colonoscopy, more participants were in
contemplation than in precontemplation in our study. The same results were observed in a
previous study among low income African Americans seen in internal medicine clinics.31
About 90% of non-adherent primary care African Americans in our study were not planning
to have CRC screening tests in the near future (i.e., were not in preparation). This finding
illustrates the challenge of promoting CRC screening behaviors in this population.
Predictors of Stage of Adoption
The results of this study were consistent with those of other studies identifying predictors of
the stage of adoption for FOBT. Factors that consistently have predicted more advanced
stage for FOBT, including this study, are older age,30 male gender,29 fewer perceived
barriers,12, 30 and provider recommendation.29, 32 In addition, higher perceived self-efficacy
predicted more advanced stage for FOBT in our study. Similarly, individuals in the
contemplation or action stages for sigmoidoscopy had greater perceived self-efficacy than
those in the pre-contemplation stage.12 Very few studies have investigated factors related to
stage of adoption for colonoscopy. In our study, predictors of being at a more advanced
stage of adoption for colonoscopy validated the limited empirical evidence available on
CRC screening behaviors: higher perceived benefits,12 higher perceived self-efficacy,12 and
having a provider recommendation29, 32, 33 were predictors of a more advanced stage for
colonoscopy.
Social Support
Few studies have identified the importance of social support for CRC screening,34 but our
findings indicate that social support may play a significant role in understanding CRC
screening behaviors among African American primary care patients. This finding was
similar to results from a study investigating mammography behaviors.35
Perhaps the most important finding in our study was that family/friend encouragement was
the next strongest predictor of advanced stage for both FOBT and colonoscopy, after
provider recommendation. In prior research among siblings of CRC patients, family
recommendation was found to be predictive of the CRC screening stage of adoption.32 Our
participants were African American primary care patients. It is possible that the group-level
(i.e., African American group) risk of CRC influences individuals' beliefs towards
preventive health behaviors36 and/or that African American families influence health
decisions surrounding CRC screening.34 Future interventions to promote CRC screening
could be peer support from a family member or friend who has undergone CRC screening.
In addition, lay health advisors could promote screening behaviors among families or friend
networks in the community.37, 38 Modes of outreach that have been suggested to promote
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health in the African American community include mobile units, faith-based groups, door-
to-door canvasing, and public schools.38
As expected, provider recommendation was the most significant predictor of advanced stage
of adoption for both FOBT and colonoscopy. In the prior literature, provider
recommendation for CRC screening and a variety of additional health care factors (e.g.,
consistent and/or recent health care usage, receipt of other cancer screenings, provider
recommendation for a colonoscopy specifically, taking prescribed medications for 6 months
or more, and having previously heard of colonoscopy) have been predictive of higher stage
of adoption for CRC screening.32, 33 Similarly, provider recommendation has been
associated with mammography stage of adoption.39 Our findings highlight the need for
providers to consistently and repeatedly endorse colon cancer screening during primary care
visits, track patients who are overdue for screening, and send reminders and educational
materials to those who need them.40
CRC Health Beliefs
Health beliefs have been examined in relation to stage of adoption studies for various health
behaviors, including mammography,41 pap smears,42 exercise adoption,43 smoking
cessation,44 dietary fat reduction,44 and daily fruit consumption.45 Stage of adoption for
CRC screening was predicted by perceived barriers, benefits, self-efficacy, and perceived
risk of CRC in prior studies. 12, 46 The results from our study suggested that tailored-
message intervention among African American primary care patients should focus on
reducing perceived barriers and improving self-efficacy if FOBT is recommended and
improving perceived benefits and self-efficacy if colonoscopy is recommended.
Demographics and Clinical Variables
For demographics, age, education, and employment have been associated with stage of
adoption in prior CRC screening studies.12, 29, 32 The male and older African American
primary care patients in our study had higher odds of being at a more advanced stage for
FOBT. The homogeneity among our participants (i.e., limited years of education and a low
employment rate) possibly contributed to our finding no significant relationships between
education or employment and stage of adoption. Not surprisingly, the VA site significantly
predicted more advanced stage for FOBT. FOBT is considered the frontline CRC screening
test in the VA system and is widely available in VA primary care clinics.20 However, based
upon the results of our post hoc test excluding the VA site, this did not change the results of
the hierarchical models substantively, suggesting that the associations between the predictor
variables assessed in this study and stage of adoption were similar between the VA site and
non-VA site patients. Participants who had an annual income of more than $30,000 had
higher odds of being at an earlier stage for colonoscopy when compared with those earning
less than $15,000 in our study. It is possible that those in the lowest income group had
government insurance, which could increase colonoscopy availability and acceptance due to
coverage for the test.47
For clinical variables, African American primary care patients with a personal history of
cancer in our study had higher odds of being at an earlier stage for FOBT. It may be that
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endoscopic CRC tests are more frequently prescribed than FOBT for cancer survivors
during specialty physician clinic visits.9
Limitations and Strengths
There are several limitations that should be considered when interpreting these results. It is
important to note that the amount of variance explained in stage of adoption was small. It is
possible that the health beliefs measured in our study did not completely capture the
perceptions of African American primary care patients. For example, the perceived risk was
operationalized at the individual level but not at the group level (i.e., among African
Americans). Group level perceptions of susceptibility have been associated with perceived
benefits of screening among African Americans.36 Other constructs that may influence stage
of adoption for CRC screening that were not measured in our study include hope (positive
attitude toward screening), fear (pain, hospital/doctor, or cancer diagnosis, surgery could
spread cancer), medical mistrust (providers do not put patients first, patients are poorly-
treated in experiments), and test preference.36, 48 Another limitation includes the potential
for selection bias as these data were from the baseline interview of an intervention study to
promote CRC screening. Individuals willing to participate in a CRC screening intervention
study might possess different characteristics, beliefs, and attitudes about CRC screening than
individuals not willing to participate in such a study. In addition, our results can only be
generalized to similar populations of low socioeconomic status (low education level, low
income, and unemployed) African Americans who have insurance and are able to access
primary care services. Our results may not be replicable among those who are not insured
and/or those who have different perspectives on screening. Finally, these analyses used a
cross-sectional design to examine stage of adoption. The predictors identified in our study
may not have causal relationships with the outcome variable. Stage of adoption was used as
the outcome, rather than actual CRC screening behavior because all participants were
overdue for screening (i.e., not in the action or maintenance stages) at baseline.
Despite these limitations, our study has a number of strengths. First, this is one of very few
studies examining predictors of stage of adoption for CRC screening among African
American primary care patients who were currently non-adherent to screening guidelines.
The findings from our study could help primary care providers to understand the
characteristics of this high risk population and so to develop effective strategies to facilitate
adherence to CRC screening recommendations. Second, we measured perceived self-
efficacy, perceived benefits, and perceived barriers separately for FOBT and colonoscopy to
better capture the information related to these specific screening tests.
Implications for Practice
The results of our study provide socioculturally relevant information to health care providers
who promote CRC screening among African American primary care patients. A self-report
questionnaire to assess CRC beliefs and knowledge, family history, and stage of adoption
for screening could be added to the pre-visit procedures in primary care clinics. In
discussing CRC screening with patients, oncology nurses and Advanced Practice Nurses can
tailor education content based on specific sociocultural characteristics, such as encouraging
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discussions with family members or friends who had positive CRC screening experiences,
reducing perceived barriers related to CRC and screening tests, highlighting the benefits of
screening, and enhancing self-efficacy to complete screening tests by using teach-back
methods for how to make appointments and complete screening tests. Nurses can encourage
patients to attend group education sessions delivered by racially concordant health care
providers in the community. Educational content should be culturally sensitive and
developed in collaboration with community members.
Two factors were found to show patients at higher odds of being at an earlier stage of
adoption: “a personal history of cancer” related to FOBT and “an annual income of more
than $30,000” related to colonoscopy. Primary care nurses need to be aware that patients
with history of cancer are more likely at an earlier stage of adoption for FOBT, because they
may not receive a recommendation for FOBT. Due to the risk of secondary or metastatic
cancer, these individuals instead may receive a recommendation for colonoscopy.9 Patients
with higher incomes probably have higher co-pays than those with lower incomes. Thus,
they may be in an earlier stage of adoption for colonoscopy. Nurses may consider offering
them annual FOBT as a CRC screening test option.
Conclusion
Culturally relevant interventions to promote CRC screening have been identified as an
effective approach to reducing CRC disparities among African Americans.49, 50 The
findings from our study illustrate the importance of social support to promote CRC
screening in this group. Culturally relevant CRC screening interventions can be delivered by
lay health advisors in the African American community along with providers giving
recommendations at the primary care clinic. Community-based participatory research
designs are suggested to bring community members into the full spectrum of research
activity, including problem identification, intervention development, intervention
implementation, and post-intervention evaluation. Active engagement of members of
African American communities will result in culturally relevant, appropriate, and effective
interventions to increase CRC screening and reduce CRC incidence and mortality. Finally,
future research among African Americans must include both insured and uninsured
populations as well as higher socioeconomic groups to examine other factors that may
influence stage of adoption and CRC screening behaviors.
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Figure. Conceptual Framework
Abbreviations: BMI, body mass index; CRC colorectal cancer; FOBT, fecal occult blood
test.
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Table 1
Stage of Adoption Definitions for FOBT and Colonoscopy
CRC Screening Tests Precontemplation Contemplation Preparation
FOBT
Never had OR had one more than 12
months ago AND does not intend to
have one in next 6 months.
Never had OR had one more than
12 months ago AND intends to
have one in next 6 months.
Never had OR had one more than
12 months ago, is planning to do in
next six months, and has an FOBT
kit.
Colonoscopy
Never had OR had one more than 10
years ago AND does not intend to have
one in next 6 months.
Never had OR had one more than
10 years ago AND intends to have
one in next 6 months.
Never had OR had one more than
10 years ago, is planning to do in
next six months, and has an
appointment scheduled.
Abbreviations: CRC colorectal cancer; FOBT, fecal occult blood test.
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Table 3
Predictors of Stage of Adoption for FOBT from Hierarchical Modelinga
Predictor Variablesb FOBT Stage of Adoption
Step 1
OR (95% CI)
Step 2
OR (95% CI)
Step 3
OR (95% CI)
Step 4
OR (95% CI)
Demographics
 Age 1.04 (1.10-1.06)** 1.04 (1.01-1.06)** 1.04 (1.01-1.06)** 1.04 (1.01-1.06)**
 Male 1.86 (1.32-2.63)** 1.68 (1.17-2.41)** 1.72 (1.19-2.48)** 1.70 (1.16-2.49)**
 Income: 15K-30K vs. < 15K 0.97 (0.69-1.35) 0.98 (0.70-1.37) 0.90 (0.64-1.27) 0.82 (0.57-1.16)
    > 30K vs. < 15K 1.15 (0.73-1.83) 1.23 (0.77-1.96) 1.06 (0.66-1.07) 1.03 (0.63-1.69)
 Insurance 1.00 (0.62-1.63) 1.01 (0.62-1.66) 1.01 (0.62-1.67) 0.94 (0.57-1.57)
 VA site 3.77 (2.47-5.77)** 3.92 (2.56-6.02)** 3.46 (2.25-5.34)** 2.80 (1.76-4.44)**
Clinical Variables
 BMI 0.98 (0.96-1.00) 0.99 (0.97-1.01) 0.98 (0.96-1.01)
 Personal History of Cancer 0.38 (0.20-0.71)** 0.38 (0.20-0.71)** 0.37 (0.19-0.70)**
CRC Health Beliefs & Knowledge
 Perceived Risk 1.05 (0.92-1.20) 1.06 (0.92-1.21)
 FOBT Benefits 1.20 (0.92-1.56) 1.15 (0.88-1.50)
 FOBT Barriers 0.79 (0.63-0.98)* 0.79 (0.63-0.99)*
 FOBT Self-efficacy 1.79 (1.28-2.49)** 1.59 (1.13-2.23)**
Social Support
 Married/Partnered 1.23 (0.88-1.72)
 Family/friend Encouragement 1.64 (1.18-2.29)**
 Provider Recommendation 2.05 (1.48-2.85)**
Generalized R2 0.126 0.140** 0.169** 0.202**
Abbreviations: BMI, body mass index; CI, confidence interval; CRC, colorectal cancer; FOBT, fecal occult blood test; K, thousand; OR, odds
ratio.
a
* p<.05, ** p<.01
bVariables with p≤.2 from the bivariate analysis.
Cancer Nurs. Author manuscript; available in PMC 2015 July 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Wang et al. Page 21
Table 4
Predictors of Stage of Adoption for Colonoscopy from Hierarchical Modelinga
Predictor Variablesb Colonoscopy Stage of Adoption
Step 1
OR (95% CI)
Step 2
OR (95% CI)
Step 3
OR (95% CI)
Step 4
OR (95% CI)
Demographics
 Age 0.98 (0.96-1.00) 0.98 (0.96-1.00)** 0.99 (0.96-1.01) 0.98 (0.96-1.00)
 Education 0.97 (0.90-1.05) 0.97 (0.90-1.05) 0.95 (0.88-1.03) 0.95 (0.88-1.04)
 Male 1.50 (1.14-1.97)** 1.37 (1.02-1.83)** 1.27 (0.94-1.71) 1.29 (0.95-1.75)
 Income: 15K-30K vs. < 15K 0.98 (0.72-1.33) 0.97 (0.72-1.33) 0.86 (0.63-1.18) 0.83 (0.60-1.14)
 Income: > 30K vs. < 15K 0.56 (0.35-0.89)** 0.57 (0.36-0.90)* 0.47 (0.29-0.75)** 0.46 (0.28-0.75)**
 Insurance 1.34 (0.87-2.07) 1.43 (0.92-2.23) 1.57 (1.00-2.47)* 1.47 (0.94-2.32)
Clinical Variables
 BMI 0.98 (0.97-1.02) 0.98 (0.88-1.03) 0.98 (0.96-1.00)
CRC Health Beliefs & Knowledge
 Perceived Risk 1.12 (0.98-1.29) 1.12 (0.97-1.28)
 Perceived Comparative Risk:
  Higher vs. Same as others 1.65 (1.09-2.51)* 1.47 (0.96-2.25)
  Lower vs. Same as others 1.02 (0.74-1.14) 1.08 (0.78-1.51)
 Colonoscopy Benefits 1.52 (1.21-1.92)** 1.56 (1.23-1.98)**
 Colonoscopy Barriers 0.89 (0.73-1.10) 0.88 (0.71-1.08)
 Colonoscopy Self-efficacy 1.77 (1.34-2.35)** 1.66 (1.25-2.22)**
Social Support
 Family/friend Encouragement 1.71 (1.23-2.36)**
 Provider Recommendation 2.47 (1.84-3.33)**
Generalized R2 0.026 0.032** 0.098** 0.162**
Abbreviations: BMI, body mass index; CI, confidence interval; CRC, colorectal cancer; K, thousand; OR, odds ratio.
a
* p<.05, ** p<.01
bVariables with p≤.2 from the bivariate analysis.
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